nickname: Regeneron21b
url: https://investor.regeneron.com/news-releases/news-release-details/independent-data-monitoring-committee-finds-clear-efficacy-regen
title: Independent data monitoring committee finds clear efficacy for regen-covâ„¢ (casirivimab with imdevimab) in phase 3 covid-19 outpatient outcomes trial
publish_date: "2021-02-25"
year: 2021
authors:
  - given: Regeneron
    family: ''
